2019 International Biomedical Accelerator Partnership Program


Taiwan's first cross-industry, academic, research, and medical international accelerator, with 8 new talents selected.

The National Biotechnology Research Park (NBRP) and AstraZeneca (AZ), a major international pharmaceutical company, jointly organized the Biomedical Industry Accelerator Pitch Day, which is the first international accelerator in Taiwan spanning industry, academia, research, and medicine, and includes start-up companies derived from research institutions such as Academia Sinica, National Institutes of Health, and Taipei Medical University. 

The core technology of the award-winning company, CancerFree Biotech, is a proprietary biomimetic organoid culture system (E.V.A. Ex Vivo Avatar) that expands tumor cells from patients' blood. EVA Select's Personalized Anti-Cancer Drug Screen reports help physicians and patients find the right drug and provide more accurate testings in the pre-development phase of new drugs.